UNITED STATES ENVIRONMENTAL PROTECTION AGENCY 

WASHINGTON, D.C. 20460 

SEP 2 9 2015 

MEMORANDUM 

OFFICE OF CHEMICAL SAFETY 

ANO POLLUTION PREVENTION 

SUBJECT: Posting EPA-HQ-OPP-2014-0293 to Regulations.gov for Public Access 

FROM: Jeannine Kausch, Regulatory Action Leader 

Biopesticides and Pollution Prevention Divisio 

0 ffice of Pesticide Progran1s 

THRU: Robert McNally, Director 

Biopesticides and Pollution Preventi 

Office of Pesticide Programs 

TO: Office of Pesticide Programs Docket 

This memorandum authorizes the posting of EPA-HQ-OPP-2014-0293 to Regulations.gov for public 

access. Pursuant to Section 3 of the Federal insecticide, Fungicide, and Rodenticide Act, Monsanto 

Company submitted an application to the EPA, seeking to register a com plant-incorporated protectant 

(PlP) (MON 87411 , EPA File Symbol: 524-ARJ). MON 87411 contains rwo new active ingredients: 

double-stranded ribonucleic acid transcript comprising a DvSnj7 inverted repeat sequence derived from 

western com rootworm (Diabrotica virgifera virgifera) (DvSnj7 dsRNA) and Bacillus thuringiensis 

Cry3Bbl protein (Bt Cry3Bbl protein) and the genetic material (vector PV-ZM1Rl 0871) necessary for 

their production in MON 87411 com (OECD Unique Identifier: MON-874 11 -9). MON 87411 is 

proposed for seed increase/breeding purposes only (no commercial release at this time) with a time 

limitation of two years and a per-season acreage cap of 15,000 acres. Given that this PIP contains new 

active ingredients and may be an action of significant interest due to the unique mode of action of one of 

its active ingredients, the EPA is requesting comments on its overall proposal to register such PIP and 

the underlying risk assessments, as specified below. that are associated with this proposal. 

The following documents will be available for a 15-day public comment period from 

SEP 2 9 2015 OCT 1 4 2015 

A. Product Characterization and Toxicology Risk Assessment for MON 87411 (Dated August 10, 

2015). 

8. Environmental Risk Assessment for MON 874 11 (Dated August 24, 2015). 
2

C. Proposed Registration Decision for DvSnf7 dsRNA and the Bt Cry3Bb1 Protein Expressed by 

MON 87411 (Dated September 29, 2015).

Submit your comments, identified by Docket ID No. EPA-HQ-OPP-2014-0293, through 

http://www.regulations.gov. Follow the on-line instructions for submitting comments.

The EPA’s policy is that all comments received will be included in the public docket without change 

and may be made available online at http://www.regulations.gov, including any personal information 

provided, unless the comment includes information claimed to be Confidential Business Information 

(CBI) or other information whose disclosure is restricted by statute. Do not submit information that you 

consider to be CBI or otherwise protected through http://www.regulations.gov. The 

http://www.regulations.gov Web site is an “anonymous access” system, which means the EPA will not 

know your identity or contact information unless you provide it in the body of your comment. If you 

submit a comment, the EPA recommends that you include your name and other contact information. If 

the EPA cannot read your comment due to technical difficulties and cannot contact you for clarification, 

the EPA may not be able to consider your comment. Electronic files should avoid the use of special 

characters, avoid any form of encryption, and be free of any defects or viruses. For additional 

information about the EPA’s public docket, visit the EPA Docket Center homepage at

http://www.epa.gov/dockets/.

Should you have any questions regarding this memorandum, please contact Jeannine Kausch by 

telephone at (703) 347-8920 or via email at kausch.jeannine@epa.gov.